Smith John Clark II Net Worth & Insider Trades
Smith John Clark II Fennec Pharmaceuticals Inc
What is Smith John Clark II's Net Worth?
The current estimated net worth of Fennec Pharmaceuticals Inc's Smith John Clark II is estimated to be about $162M . Smith John Clark II owns about 4,077,214 units of Fennec Pharmaceuticals Inc common stock. Recently at Fennec Pharmaceuticals Inc, Smith John Clark II has sold an estimated value of $0 worth.
What is Smith John Clark II's Past Insider Trading?
Smith John Clark II's largest purchase order was 80,000 units , worth over $500K on May 6, 2020. In total, Smith John Clark II has made about 1 transaction recently at Fennec Pharmaceuticals Inc. Smith John Clark II usually trades in May, with the busiest year in 2020.
Southpoint Capital Advisors LP, Southpoint Capital Advisors LLC, Southpoint GP LP, Southpoint GP LLC, Smith John Clark II
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
What is Smith John Clark II's' Mailing Address?
- Mailing address is 1114 Avenue of the Americas 22nd Floor New York NY 10036 NY
What are Fennec Pharmaceuticals Inc's Past Insider Trades?
Fennec Pharmaceuticals Inc's most recent insider trade came on May 19, 2023 by Chris A Rallis who sold 1,758 units worth $12.94K . In the last 6 years, insiders at Fennec Pharmaceuticals Inc have sold an estimated value of $13.31M and bought an estimated value of $11.18M worth of shares. Insider trading is most common in June, with the busiest year in 2018. The most active traders at the company are Chris A Rallis, Rostislav Raykov, CHIEF EXECUTIVE OFFICER, and Robert Andrade, CHIEF FINANCIAL OFFICER .
FENNEC PHARMACEUTICALS INC. Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||